Avamed Synergy launches EUR 5m funding round to put its product on the market
Avamed Synergy lanza ronda de financiación de EUR 5m para sacar su producto al mercado
Intel ID : 413650
Relevant Documents
| Press Release | 10 Apr 2025 | Avamed_Synergy_Nota_de_Prensa_2025.pdf | ES |
|
| Intel ID | 413650 | |
| Value | EUR 5,00m | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Avamed Synergy
(31 Dec 2022) |
Revenue: EUR 0,39m EBITDA: EUR 0,03m Net Debt: EUR 3,58m People: 9 |
|
| Date |
 |
|
| Country | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Primary Subsector (TTRSC) |
30.04.01 Clinical Decision Support (CDS) (Primary) 30 Healthcare / 30.04 Healthcare Information & Technology Systems |
|
| Type |
 |
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.04.01 Clinical Decision Support (CDS) 30 Healthcare / 30.04 Healthcare Information & Technology Systems |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.